Anti-TNFalpha therapy and vaccination of adults.
Duchet-Niedziolka
Paula
P
Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Cochin Saint-Vincent de Paul, Pôle de Médecine, Paris, France.
Coutsinos
Zoé
Z
Hanslik
Thomas
T
Launay
Odile
O
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000276:immunology; D009894:Opportunistic Infections / Q000139:chemically induced / Q000276:immunology / Q000517:prevention & control; D022242:Pneumococcal Vaccines / Q000008:administration & dosage / Q000276:immunology; D017410:Practice Guidelines as Topic; D012141:Respiratory Tract Infections / Q000139:chemically induced / Q000276:immunology / Q000517:prevention & control; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology*; D014611:Vaccination / Q000379:methods*; D014612:Vaccines / Q000008:administration & dosage* / Q000276:immunology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007252:Influenza Vaccines; D022242:Pneumococcal Vaccines; D014409:Tumor Necrosis Factor-alpha; D014612:Vaccines